{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:47:28Z","timestamp":1778917648590,"version":"3.51.4"},"reference-count":117,"publisher":"Baishideng Publishing Group Inc.","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i33.11700","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:27:19Z","timestamp":1410222439000},"page":"11700","source":"Crossref","is-referenced-by-count":20,"title":["Advances in the management of peritoneal mesothelioma"],"prefix":"10.3748","volume":"20","author":[{"given":"Ali","family":"Raza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Blackham AU, Levine EA. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma. European J Clin Med Oncol 2012;4:25-32."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Kindler HL. Peritoneal Mesothelioma: The Site of Origin Matters. American Society of Clinical Oncology EDUCATIONAL BOOK Alexandria, VA: ASCO; 2013;182-187.","DOI":"10.1200\/EdBook_AM.2013.33.182"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl345"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21167"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-009-9328-9"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.05.041"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2547-4"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Welch LS, Acherman YI, Haile E, Sokas RK, Sugarbaker PH. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health 2005;11:254-258.","DOI":"10.1179\/oeh.2005.11.3.254"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl428"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.23"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl060"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2012.07.010"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp307"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med 1988;45:182-187.","DOI":"10.1136\/oem.45.3.182"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20836"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.08.1753"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182478bb5"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-011-0151-7"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2009.04.007"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9192-8"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21787"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.012"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Rogoff EE, Hilaris BS, Huvos AG. Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation. Cancer 1973;32:656-664.","DOI":"10.1002\/1097-0142(197309)32:3<656::AID-CNCR2820320319>3.0.CO;2-U"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999;70:6-12.","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"van Gelder T, Hoogsteden HC, Versnel MA, de Beer PH, Vandenbroucke JP, Planteydt HT. Malignant peritoneal mesothelioma: a series of 19 cases. Digestion 1989;43:222-227.","DOI":"10.1159\/000199880"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982;96:746-755.","DOI":"10.7326\/0003-4819-96-6-746"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.009"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.08.013"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2868"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Markman M, Kelsen D. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 1992;118:547-550.","DOI":"10.1007\/BF01225271"},{"key":"ref31","unstructured":"Kirmani SCS, Mowry J. Intracavitary cisplatin for malignant mesothelioma: an update. Proc Am Clin Oncol 1988;7:Abstract 1057."},{"key":"ref32","unstructured":"Ma GY, Bartlett DL, Reed E, Figg WD, Lush RM, Lee KB, Libutti SK, Alexander HR. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma. Cancer J Sci Am 1997;3:174-179."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Park BJ, Alexander HR, Libutti SK, Wu P, Royalty D, Kranda KC, Bartlett DL. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 1999;6:582-590.","DOI":"10.1007\/s10434-999-0582-6"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.05.027"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0756-2"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9475-8"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/jso.10255"},{"key":"ref38","unstructured":"Deraco M, De Simone M, Rossi CR, Cavaliere F, Difilippo F, Scuderi S, Pilatti P, Kusamura S. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma. J Exp Clin Cancer Res 2003;22:41-45."},{"key":"ref39","unstructured":"Deraco M, Kusamura S, Baratti D, Casali P, Zaffaroni N. [Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research]. Tumori 2003;89:56-57."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.03.045"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9169-7"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9640"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25640"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9187-5"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.05.009"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr477"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.01.001"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.150"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1080-6"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2845-x"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21239"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3341-7"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2237-2"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2010.07.001"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3180684181"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Piccigallo E, Jeffers LJ, Reddy KR, Caldironi MW, Parenti A, Schiff ER. Malignant peritoneal mesothelioma. A clinical and laparoscopic study of ten cases. Dig Dis Sci 1988;33:633-639.","DOI":"10.1007\/BF01798369"},{"key":"ref57","unstructured":"Laterza B, Kusamura S, Baratti D, Oliva GD, Deraco M. Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma. In Vivo 2009;23:187-190."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-013-1408-2"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2651-5"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Elias D, Bedard V, Bouzid T, Duvillard P, Kohneh-Sharhi N, Raynard B, Goere D. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol 2007;31:784-788.","DOI":"10.1016\/S0399-8320(07)73964-7"},{"key":"ref61","unstructured":"Costamagna D, Scuderi S, Vaira M, Barone R, De Simone M. [Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy]. Tumori 2003;89:40-42."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2008.09.010"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-88"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.1725"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25555"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.08.028"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0062"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0869"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006941"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081919"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.5301\/jbm.5000038"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2013.784777"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/nri2974"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1124\/pr.107.07113"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/nature09128"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176709"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.064162"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-219618"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.02.011"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 2008;9:662-673.","DOI":"10.2174\/138945008785132402"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2227-684X.2012.07.01"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Nagahashi M, Ramachandran S, Rashid OM, Takabe K. Lymphangiogenesis: a new player in cancer progression. World J Gastroenterol 2010;16:4003-4012.","DOI":"10.3748\/wjg.v16.i32.4003"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2012.0010"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2167"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.11.013"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2013.10.001"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3390\/biom3030408"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045330"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2008.111"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-1511-4_1"},{"key":"ref91","unstructured":"Chun J, Brinkmann V. A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya). Discov Med 2011;12:213-228."},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406512200"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506293200"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2628"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0910fje"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00476.x"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1038\/nature02284"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115628"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200176200"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Pitman MR, Woodcock JM, Lopez AF, Pitson SM. Molecular targets of FTY720 (fingolimod). Curr Mol Med 2012;12:1207-1219.","DOI":"10.2174\/156652412803833599"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2765"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.220756"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1388"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2010.05.022"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-492181"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201283"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-053884"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24003"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181b9ca69"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1903-6"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-363879"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 2001;67:999-1003.","DOI":"10.1177\/000313480106701019"},{"key":"ref113","unstructured":"G&oacute;mez Portilla A, Cendoya I, Muriel J, Olabarria I, Guede N, Moraza N, Fern&aacute;ndez E, Mart&iacute;nez de Lecea C, Magrach L, Mart&iacute;n E. [Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia]. Cir Esp 2007;81:82-86."},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Passot G, Cotte E, Brigand C, Beaujard AC, Isaac S, Gilly FN, Glehen O. [Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy]. J Chir (Paris) 2008;145:447-453.","DOI":"10.1016\/S0021-7697(08)74654-4"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21177"},{"key":"ref116","unstructured":"Baratti D, Kusamura S, Sironi A, Cabras A, Fumagalli L, Laterza B, Deraco M. Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). In Vivo 2008;22:153-157."},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2010.08.130"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i33\/11700.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T12:51:06Z","timestamp":1689511866000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i33\/11700.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":117,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i33.11700","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}